The purpose of this article is to review the status and limitations of anatomic tumor response
metrics including the World Health Organization (WHO) criteria, the Response Evaluation …

Hypothesis The 2-[18 F]-fluoro-2-deoxy-d-glucose positron emission tomography is an
imaging tool for assessing clinical tumor, node, metastasis in non-small cell lung cancer …

Purpose To determine whether whole-body total lesion glycolysis (TLG), which combines
volumetric and metabolic information from fluorine 18 fluorodeoxyglucose (FDG) positron …

Introduction Few validated prognostic factors are available for survival in patients with lung
cancer.[18 F]-fluoro-2-deoxy-d-glucose positron emission tomography has been shown to …

BACKGROUND. The objective of this study was to evaluate cervical tumor uptake of F‐18
fluorodeoxyglucose (FDG) measured as the maximal standardized uptake value (SUVmax) …

Introduction: The 2-[18F]-Fluorodeoxyglucose (FDG) positron emission tomography
(PET/CT) has become an imaging tool for clinical assessment of tumor, node, metastasis in …

Imaging of tumour response to therapy has steadily evolved over the past few years as a
result of advances in existing imaging modalities and the introduction of new functional …

Introduction Recent developments of diffusion-weighted magnetic resonance imaging (DWI)
make it possible to image malignant tumors to provide tissue contrast based on difference in …

PURPOSE: Each pathological stage of non-small cell lung cancer (NSCLC) consists of a
heterogeneous population containing patients at much higher risk than others. Noninvasive …

Purpose: This study aimed to investigate whether metabolic tumor volume (MTV) measured
from [18F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG …